drugset / Trial / NCT00278057

STUDY OF GLUCOSE IN DIALYSIS WATER WITH REGARD TO BLOOD PRESSURE AND QUALITY OF LIFE

NCT00278057

Phase 4 Completed 55 enrolled Regional Hospital Holstebro

Summary

We wanted to test the hypotheses that blood pressure level was lower, that the variability of blood pressure and blood glucose was reduced, and that quality of life was improved when glucose was added to the dialysis fluid.

Timeline

Start
2003-05
Primary completion
Completion
2003-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Glucose Unknown

Indications

No indication recorded.